1. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. Broad Institute of MIT and Harvard, Cambridge, MA;
3. Division of Hematology, Brigham and Women’s Hospital, Boston, MA;
4. Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA;
5. Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;
6. Department of Pathology, Massachusetts General Hospital, Boston, MA;
7. Department of Academic Haematology, University College London Cancer Institute, London, United Kingdom; and
8. Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA